用户名: 密   码:
注册 | 忘记密码?
药品详细

Lymecycline (Lymecycline )

化学结构式图
中文名
Lymecycline
英文名
Lymecycline
分子式
Not Available
化学名
(2S)-6-[({[(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracen-2-yl]formamido}methyl)amino]-2-aminohexanoic acid
分子量
Average: 602.6328
Monoisotopic: 602.258793456
CAS号
992-21-2
ATC分类
J01A 未知
药物类型
small molecule
阶段
商品名
Acronize;Acronize PD;Aureocarmyl;Aureociclin;Aureociclina;Aureocina;Aureocycline;Aureomicina;Aureomycin;Aureomycin A-377;Aureomycin hydrochloride;Aureomycin monohydrochloride;Aureomykoin;Aurofac;Aurofac 10;Auxeomycin;B-Aureo;Biomitsin;Biomitsin hydrochloride;Biomycin A;Biomycin hydrochloride;Biovetin;Centraureo;Chrusomykine;Chrysomykine;Clorocipan;Duomycin;Flamycin;Isphamycin;Orospray;Psittacin hydrochloride;Tetra 5;Tetralysal;Tetrlysal 300;Tocopherex;
同义名
7-Chlorotetracycline;Chlorotetracycline;Chlorotetracycline hydrochloride;Chlortetracyclin;Chlortetracycline;Chlortetracycline hydrochloride;Chlortetracyclinium chloride;CLTC;
基本介绍

A tetracycline with a 7-chloro substitution. [PubChem]

生产厂家
  • Lederle laboratories div american cyanamid co
封装厂家
参考
Synthesis Reference Not Available
General Reference
  1. Link
  2. Meynadier J, Alirezai M: Systemic antibiotics for acne. Dermatology. 1998;196(1):135-9. Pubmed
剂型
Form Route Strength
Capsule Oral
规格
化合物类型
Type small molecule
Classes
  • Tetracyclines
  • Amino Acids
Substructures
  • Tetracyclines
  • Hydroxy Compounds
  • Benzyl Alcohols and Derivatives
  • Naphthalenes
  • Acetates
  • Phenols and Derivatives
  • Amino Ketones
  • Aliphatic and Aryl Amines
  • Benzene and Derivatives
  • Carboxylic Acids and Derivatives
  • Aminals and Derivatives
  • Alcohols and Polyols
  • Aromatic compounds
  • Carboxamides and Derivatives
  • Amino Acids
  • Benzoyl Derivatives
  • Cyclohexenes and Derivatives
  • Phenyl Esters
  • Enols
  • Ketones
适应症
antibacterials 抗细菌;
药理
Indication For the treatment of infections and to treat acne. It may also be used to treat urinary tract infections, gum disease, and other bacterial infections such as gonorrhea and chlamydia. Lymecycline is also used commonly as a prophylactic treatment for infection by Bacillus anthracis (anthrax). It is also effective against Yersinia pestis and malaria and is also prescribed for the treatment of Lyme disease.
Pharmacodynamics Lymecycline is a tetracycline broad-spectrum antibiotic. It is approximately 5000 times more soluble than tetracycline base and is unique amongst tetracyclines in that it is absorbed by the "active transport" process across the intestinal wall, making use of the same fast and efficient mechanism by which carbohydrates are absorbed. It inhibits cell growth by inhibiting translation.
Mechanism of action Lymecycline inhibits cell growth by inhibiting translation. It binds to the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome. The binding is reversible in nature. Lymecycline is lipophilic and can easily pass through the cell membrane or passively diffuses through porin channels in the bacterial membrane. Cells become resistant to lymecycline by at least two mechanisms: efflux and ribosomal protection. In efflux, a resistance gene encodes a membrane protein that actively pumps lymecycline out of the cell. This is the mechanism of action of the tetracycline resistance gene on the artificial plasmid pBR322. In ribosomal protection, a resistance gene encodes a protein which binds to the ribosome and prevents lymecycline from acting on the ribosome.
Absorption Absorption is fast and efficient. Bioavailability is 100% following oral administration.
Volume of distribution Not Available
Protein binding Not Available
Metabolism
Route of elimination Not Available
Half life Not Available
Clearance Not Available
Toxicity Adverse effects include nausea, vomiting, diarrhoea, glossitis, enterocolitis, dysphagia, dermatitis, hypersensitivity reactions, proctitis, and vaginitis.
Affected organisms
  • Enteric bacteria and other eubacteria
Pathways
Pathway Name SMPDB ID
Smp00295 Lymecycline Pathway SMP00295
理化性质
Properties
State solid
Melting point Not Available
Experimental Properties
Property Value Source
water solubility Soluble (at all physiological pH values) PhysProp
logP 0.3 PhysProp
Predicted Properties
Property Value Source
water solubility 1.31e+00 g/l ALOGPS
logP -0.27 ALOGPS
logP -8.52 ChemAxon Molconvert
logS -2.66 ALOGPS
pKa 3.44 ChemAxon Molconvert
hydrogen acceptor count 13 ChemAxon Molconvert
hydrogen donor count 9 ChemAxon Molconvert
polar surface area 242.98 ChemAxon Molconvert
rotatable bond count 10 ChemAxon Molconvert
refractivity 154.51 ChemAxon Molconvert
polarizability 62.88 ChemAxon Molconvert
药物相互作用
食物相互作用
  • Do not to take any indigestion remedies, iron or zinc supplements at the same time as this medicine.

返回 | 收藏